Market Place
Sourcing Support
Founder Of Hua Medicine Dr.Chen Awarded C. C. Tan Life Science Award
24 Oct 2024 //
PR NEWSWIRE
Bayer, Hua snag first-in-class diabetes nod for Roche castoff
11 Oct 2022 //
FIERCEPHARMA
Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin
26 Sep 2021 //
SCOOP
Hua and Sinopharm Announced Supply Chain Strategic Cooperation
15 Sep 2021 //
ASIAONE
Hua Medicine, Bayer bring novel diabetes treatment in China
19 Aug 2020 //
BIOSPECTRUMASIA
Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin
02 Jul 2020 //
ACNNEWSWIRE
Two years in, Hong Kong’s biotech experiment has been validated
18 May 2020 //
ENDPTS
Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin
27 Apr 2020 //
GLOBENEWSWIRE
Hua Medicine appoints former U.S. FDA Officer as CTO
18 Feb 2020 //
BIOSPECTRUMASIA
ARCH-backed Chinese biotech scores PhIII win for glucokinase diabetes drug
13 Nov 2019 //
ENDPTS
Nine listings and $3.8B later, HKEX celebrates one-year biotech $194M CRO IPO
26 Apr 2019 //
ENDPTS
Oncology dominates a ‘Cambrian explosion’ in China’s drug pipeline
18 Mar 2019 //
ENDPTS
Junshi Biosciences aims for $414M Hong Kong IPO: Reuters
11 Dec 2018 //
FIERCE BIOTECH
Arch Venture sets its sights on raising $600M for Fund X
30 Oct 2018 //
ENDPTS
A photo log of my week in Shanghai-US-China Biopharma Innovation and Investment Summit
29 Oct 2018 //
ENDPTS
Innovent to seek $400M-plus on Hong Kong IPO
16 Oct 2018 //
ENDPTS
WuXi AppTec files for public listing in Hong Kong 4 months after Shanghai IPO
18 Sep 2018 //
ENDPTS
Hua Medicine reaps $110.5M, adjusting expectations for Hong Kong IPO
15 Sep 2018 //
ENDPTS
Making Hong Kong history, Ascletis eyes $457M haul in GIC-backed IPO
18 Jul 2018 //
ENDPTS
Tasly Gains Products As Transgene Sells Up China JV Stake
11 Jul 2018 //
ENDPTS
HUA MEDICINE PLANNING HONG KONG IPO
07 Jun 2018 //
BIOCENTURY
Eyeing NDA for its diabetes drug, Hua Medicine files IPO
06 Jun 2018 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.